We have launched Asper Nephrology testing portfolio to expand our testing menu and cover more clinical areas. The new portfolio includes tests for common monogenic diseases, as well as complex disorders. To establish the genetic cause of renal diseases we use next-generation sequencing technology to accommodate a broad differential diagnosis. CNV analysis based on sequencing data is also available to enhance precise diagnosis. Visit https://www.asperbio.com/asper-nephrology/ to see the full list of tests.
CNV analysis
Published 13/08/2019We have integrated copy number variation (CNV) detection tool into our everyday workflow. CNV analysis is now available as a new testing option for all NGS panels and whole exome sequencing.
View the complete list of all tests www.asperbio.com/genetic-tests/
New Offerings in Asper Neurogenetics
Published 07/08/2019Asper Neurogenetics testing portfolio has been updated with Brunner syndrome test, and CNV analysis for all gene panels. See complete Asper Neurogenetics test menu here https://www.asperbio.com/asper-neurogenetics/